• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAYLIS MEDICAL COMPANY INC. NRG TRANSSEPTAL NEEDLE; CATHETER, SEPTOSTOMY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAYLIS MEDICAL COMPANY INC. NRG TRANSSEPTAL NEEDLE; CATHETER, SEPTOSTOMY Back to Search Results
Lot Number NGFA130921
Medical Device Problem Codes Device Markings/Labelling Problem (2911); Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 03/10/2023
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that an nrg transseptal needle experienced an issue with the label being torn.No patient complications reported.Device and procedure outcome are unknown.Product is expected to return for analysis.
 
Additional Manufacturer Narrative
The device was returned for analysis.Based on the testing of the returned product, the allegation is not confirmed, as there was no evidence of a torn label.Additionally, through investigation and review of the media provided, there was presence of foreign material and a handle defect.An analysis of the device found that the original packaging was returned with no issues on the label and the sterile seal was found sealed.Upon opening the package, an embedded particulate was found, located next to the plastic tray close to the connector cable.The sterile seal was then opened, and upon closer inspection, the particulate was a flat black mark embedded into the pouch.The particulate does not meet acceptance criteria for loose particulate, and is therefore considered a failure.In addition, a handle defect was also identified on the thread at the proximal end of the hub.The defect was measured, which although it passes the maximum allowable size, it fails the design spec.An initial mdr is required to report investigation results.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NRG TRANSSEPTAL NEEDLE
Common Device Name
CATHETER, SEPTOSTOMY
Manufacturer (Section D)
BAYLIS MEDICAL COMPANY INC.
5959 trans-canada highway
montreal H4T 1 A1
CA  H4T 1A1
Manufacturer (Section G)
BAYLIS MEDICAL COMPANY INC.
5825 explorer drive
mississauga, on L4W 5 P6
CA   L4W 5P6
Manufacturer Contact
timothy degroot
4100 hamline avenue north
dc a330
saint paul, MN 55112
6515826168
MDR Report Key18914426
Report Number2124215-2024-15265
Device Sequence Number7042439
Product Code DXF
UDI-Device Identifier00685447000211
UDI-Public00685447000211
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
K073326
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Other,Foreign
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date (Section B) 03/15/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Other
Device Expiration Date09/13/2024
Device Lot NumberNGFA130921
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/21/2023
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 02/16/2024
Initial Report FDA Received Date03/15/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured09/30/2021
Is the Device Labeled for Single Use? (Y/N) Yes
Usage of Device Unknown
Patient Sequence Number1
Patient SexUnknown
-
-